BARD1, AN ONCOGENIC DRIVER AND BIOMARKER OF LUNG CANCER

被引：0
|
作者：
Pilyugin, M. [1 ,2 ]
Andre, P. [1 ,2 ]
Laurent, G. [3 ]
Irminger-Finger, I. [1 ,2 ,3 ]
机构：
[1] Univ Hosp Geneva, Dept Gynecol Obstet, Mol Gynecol & Obstet Lab, Geneva, Switzerland
[2] Univ Hosp Geneva, Dept Med Genet & Labs, Geneva, Switzerland
[3] Univ Western Australia, Sch Med & Pharmacol, Ctr Cell Therapy & Regenerat Med, Nedlands, WA 6009, Australia
来源：
RESPIROLOGY | 2014年 / 19卷
关键词：
D O I：
10.1111/resp.12263_11
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [31] Cancer predisposing BARD1 mutations in breast-ovarian cancer families
    Magdalena Ratajska
    Magdalena Matusiak
    Izabela Brożek
    Maciej Stukan
    Marcin Śniadecki
    Jarosław Dębniak
    Dariusz Wydra
    Janusz Limon
    Hereditary Cancer in Clinical Practice, 10 (Suppl 4)
  • [32] Exploring prevalence of BARD1 pathogenic variant in breast cancer patients
    Valintelis, Albertas
    Drejeriene, Ieva
    Norvydas, Matas
    Gruode, Jurate
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 905 - 905
  • [33] Screening for mutations in the BARD1 gene in families with ovarian cancer.
    Ramus, SJ
    Baer, R
    Foster, NA
    Dunning, AM
    Harrington, PA
    Gayther, SA
    Ponder, BAJ
    Bowcock, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A79 - A79
  • [34] CLIP1-LTK: A novel oncogenic driver in lung cancer
    Izumi, Hiroki
    Matsumoto, Shingo
    Kobayashi, Susumu
    Goto, Koichi
    CANCER SCIENCE, 2023, 114 : 875 - 875
  • [35] BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer
    Pilyugin, Maxim
    Ratajska, Magdalena
    Stukan, Maciej
    Concin, Nicole
    Zeillinger, Robert
    Irminger-Finger, Irmgard
    GENES, 2021, 12 (07)
  • [36] Mutational analysis of BARD1 in familial breast cancer patients in Japan
    Ishitobi, M
    Miyoshi, Y
    Hasegawa, S
    Egawa, C
    Tamaki, Y
    Monden, M
    Noguchi, S
    CANCER LETTERS, 2003, 200 (01) : 1 - 7
  • [37] Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?
    Stempa, Klaudia
    Wokolorczyk, Dominika
    Kluzniak, Wojciech
    Rogoza-Janiszewska, Emilia
    Malinska, Karolina
    Rudnicka, Helena
    Huzarski, Tomasz
    Gronwald, Jacek
    Gliniewicz, Katarzyna
    Debniak, Tadeusz
    Jakubowska, Anna
    Lener, Marcin
    Tomiczek-Szwiec, Joanna
    Domagala, Pawel
    Suszynska, Malwina
    Kozlowski, Piotr
    Kluz, Tomasz
    Naczk, Mariusz
    Lubinski, Jan
    Narod, Steven A.
    Akbari, Mohammad R.
    Cybulski, Cezary
    CANCERS, 2021, 13 (21)
  • [38] A BARD1 autoimmune antibodies test for early detection of ovarian cancer
    Pilyugin, Maxim
    Ratajska, Magda
    Cohen, Marie
    Irminger-Finger, Irmgard
    CANCER RESEARCH, 2020, 80 (16)
  • [39] Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer
    Ozkan Ozden
    Faraz Bishehsari
    Jessica Bauer
    Seong-Hoon Park
    Arundhati Jana
    Seung Hyun Baik
    Judith C. Sporn
    Jonas J. Staudacher
    Cemal Yazici
    Nancy Krett
    Barbara Jung
    Scientific Reports, 6
  • [40] Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer
    Ozden, Ozkan
    Bishehsari, Faraz
    Bauer, Jessica
    Park, Seong-Hoon
    Jana, Arundhati
    Baik, Seung Hyun
    Sporn, Judith C.
    Staudacher, Jonas J.
    Yazici, Cemal
    Krett, Nancy
    Jung, Barbara
    SCIENTIFIC REPORTS, 2016, 6
12345